Post by Lonza

Name: Biologics candidates often fail due to manufacturability, stability or immunosafety issues, which co
Uploaded: 2026-07-06T08:00:26.305Z
Channel: Lonza
Description: Biologics candidates often fail due to manufacturability, stability or immunosafety issues, which could have been identified earlier. That's why we've made early de-risking more accessible for early

468,482 followers

Biologics candidates often fail due to manufacturability, stability or immunosafety issues, which could have been identified earlier. That's why we've made early de-risking more accessible for early-stage developers. By combining in silico developability assessment, small-scale protein expression and PBMC activation screening, our integrated package is designed to help answer two critical questions early: Is it safe? Can it be manufactured? So you can identify risks sooner, plan with greater clarity and avoid costly surprises down the line. Your IND starts long before GMP. So do we. Learn more here: https://ow.ly/xMiX50ZjQHV #Biologics #EarlyDevelopment #INDReadiness #CDMO

Video Content